Sanlao, Crispina R.

HRN: 04-74-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2022
AZITHROMYCIN 500MG TABLET (TAB)
07/28/2022
08/01/2022
PO
500mg
OD
CAP MR
Waiting Final Action 
07/28/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/28/2022
08/03/2022
IV
500mg
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: